Search

Search Constraints

You searched for: Author/Creator Pond, Gregory R

Search Results

2. Conditional immune toxicity rate in patients with metastatic renal and urothelial cancer treated with immune checkpoint inhibitors. Issue 1 (30th March 2020)

4. Neurocognitive impairment, neurobehavioral symptoms, fatigue, sleep disturbance, and depressive symptoms in patients with newly diagnosed glioblastoma. Issue 1 (13th September 2022)

5. Potential value of Gleason score in predicting the benefit of cabazitaxel in metastatic castration-resistant prostate cancer. (June 2013)

6. Potential value of Gleason score in predicting the benefit of cabazitaxel in metastatic castration-resistant prostate cancer. (June 2013)

7. Potential value of Gleason score in predicting the benefit of cabazitaxel in metastatic castration-resistant prostate cancer. (June 2013)

8. Seamless Designs: Current Practice and Considerations for Early-Phase Drug Development in Oncology. (17th December 2018)

9. Trial marketing in the Pan-Canadian Early Detection of Lung Cancer Study. (April 2020)